Practical, Catalytic Enantioselective Hydrogenation to SynthesizeN-Unprotected β-Amino Esters-Reference-Cited by-同舟云学术

Practical, Catalytic Enantioselective Hydrogenation to SynthesizeN-Unprotected β-Amino Esters

Published:2011-08-26 Issue:5 Volume:15 Page:1130-1137
ISSN:1083-6160
Container-title:Organic Process Research & Development
language:en
Short-container-title:Org. Process Res. Dev.

Author:

Matsumura Kazuhiko¹,Zhang Xiaoyong¹,Hori Kiyoto¹,Murayama Toshiyuki¹,Ohmiya Tadamasa¹,Shimizu Hideo¹,Saito Takao¹,Sayo Noboru¹

Affiliation:

1. Corporate Research and Development Division, Takasago International Corporation, 4-11, Nishiyawata 1-chome, Hiratsuka City, Kanagawa 254-0073, Japan

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Physical and Theoretical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/op2001035

Reference41 articles.

1. Asymmetric synthesis of ß-amino acids and α-substituted β-amino acids

2. Recent Developments in the Catalytic Asymmetric Synthesis of α- and β-Amino Acids

3. Enantioselective Synthesis of β-Amino Acids

4. Recent advances in the catalytic asymmetric synthesis of β-amino acids

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a Scalable, Stereoselective Second-Generation Route for CXCR7 Antagonist ACT-1004-1239 via Chiral Enamine Reduction and a Novel Telescoped Sequence of Transesterification, cis-to-trans Epimerization, and Saponification;Organic Process Research & Development;2024-01-22

2. Anwendung von Organometallkatalysatoren in der API-Synthese;Organometallik in der Prozesschemie;2024

3. Enantioselective Transformations in the Synthesis of Therapeutic Agents;Chemical Reviews;2023-07-07

4. Enantioselective and Step-Economic Synthesis of the Chiral Amine Fragment in the Tyrosine Kinase Inhibitor Repotrectinib by Direct Asymmetric Reductive Amination under Batch and Flow;Organic Process Research & Development;2023-07-06

5. Ruthenium-Catalyzed Direct Asymmetric Reductive Amination for the Synthesis of a Chiral Primary Amine Intermediate En Route to a PDE2A Inhibitor, TAK-915;Organic Process Research & Development;2023-04-27